In a filing, Ginkgo Bioworks Holdings Inc revealed its Officer Che Austin acquired Company’s shares for reported $1377.0 on Feb 07 ’25. In the deal valued at $13.91 per share,99 shares were bought.
Then, Coen Steven P. sold 367 shares, generating $4,934 in total proceeds. Upon selling the shares at $13.44, the insider now owns 7,664 shares.
Before that, Dmytruk Mark E. sold 740 shares. Ginkgo Bioworks Holdings Inc shares valued at $9,948 were divested by the insider at a price of $13.44 per share. As a result of the transaction, Dmytruk Mark E. now holds 33,963 shares, worth roughly $0.48 million.
BTIG Research downgraded its Ginkgo Bioworks Holdings Inc [DNA] rating to a Sell from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including William Blair’s analysts, who decreased its forecast for the stock in early May from “a Mkt perform” to “an Underperform”. Raymond James also remained covering DNA and has decreased its forecast on November 14, 2023 with a “Mkt perform” recommendation from previously “an Outperform” rating. BTIG Research revised its rating on November 09, 2023. It rated DNA as “a Neutral” which previously was an “a Buy”.
Price Performance Review of DNA
On Friday, Ginkgo Bioworks Holdings Inc [NYSE:DNA] saw its stock jump 4.17% to $14.25. Over the last five days, the stock has gained 6.66%. Ginkgo Bioworks Holdings Inc shares have risen nearly 45.11% since the year began. Nevertheless, the stocks have fallen -72.38% over the past one year. While a 52-week high of $64.40 was reached on 02/06/25, a 52-week low of $5.26 was recorded on 01/14/25. SMA at 50 days reached $10.79, while 200 days put it at $13.60.
Levels Of Support And Resistance For DNA Stock
The 24-hour chart illustrates a support level at 13.41, which if violated will result in even more drops to 12.57. On the upside, there is a resistance level at 14.94. A further resistance level may holdings at 15.64. The Relative Strength Index (RSI) on the 14-day chart is 58.72, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.51, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 44.22%. Stochastics %K at 67.81% indicates the stock is a holding.
How much short interest is there in Ginkgo Bioworks Holdings Inc?
A steep rise in short interest was recorded in Ginkgo Bioworks Holdings Inc stocks on 2025-01-15, growing by 0.65 million shares to a total of 7.83 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 7.17 million shares. There was a rise of 8.34%, which implies that there is a positive sentiment for the stock.
